Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

The document concluded that there were no effective ways to prevent hair loss from chemotherapy but treatments were being explored.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

GLP-1 agonists may increase the risk of hair loss.

Valproic acid is effective but often causes side effects like weight gain and hair loss, so personalized treatment is needed.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

Some people have severe allergic reactions to anthelminthic drugs, but these are often due to the parasites, not the drugs.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Alitretinoin may help treat alopecia areata.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Platelet-rich plasma treatment significantly increased hair regrowth and decreased discomfort in alopecia patients, making it a potentially better and safer treatment option.

Tofacitinib might be used to treat hair loss.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Combining DPCP with PRP doesn't improve hair regrowth in alopecia areata.

Imuvert can prevent some chemotherapy-induced hair loss.

New butyric acid prodrugs show promise for cancer treatment, anemia management, and protecting hair from chemotherapy damage.

Nanogels with hydrophobic modifications improve oral drug delivery for intestinal disease treatment.

Injecting platelet-rich plasma into the muscle layer improves intestinal healing and reduces adhesions.

Extended-release divalproex is better tolerated and more effective for seizures and psychiatric symptoms than delayed-release divalproex, but doesn't reduce hair loss.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Bitter Apple has various medicinal uses, including treating tumors, skin conditions, ulcers, asthma, jaundice, and rheumatism.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Cepharanthine may help treat gastric cancer by causing cancer cell death and affecting energy use.